Moving a novel gene therapy paradigm to treat blindness to the market

Project Information

inSight

Grant agreement ID: 813223

DOI

10.3030/813223

Project closed

EC signature date 17 May 2019

Start date 1 June 2019

End date 31 May 2021

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 150 000,00

EU contribution

€ 150 000,00

Coordinated by

UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II
Italy

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Challenging Safety and Efficacy of Retinal Gene Therapies by Retinogenesis

Author(s): Elena Marrocco, Rosa Maritato, Salvatore Botta, Marianna Esposito, Enrico Maria Surace
Published in: International Journal of Molecular Sciences, Issue 22/11, 2021, Page(s) 5767, ISSN 1422-0067
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms22115767

Intellectual Property Rights

Patent (2)

ARTIFICIAL DNA-BINDING PROTEINS AND USES THEREOF

Application/Publication number: 14 802414
Date: 2014-11-20
Applicant(s): FONDAZIONE TELETHON ETS

SYNTHETIC PROMOTERS AND USES THEREOF

Application/Publication number: 17 704246
Date: 2017-02-09
Applicant(s): FONDAZIONE TELETHON ETS